150 related articles for article (PubMed ID: 29338090)
1. Influence of provider factors and race on uptake of breast cancer gene expression profiling.
Reeder-Hayes KE; Wheeler SB; Baggett CD; Zhou X; Meng K; Roberts MC; Carey LA; Meyer AM
Cancer; 2018 Apr; 124(8):1743-1751. PubMed ID: 29338090
[TBL] [Abstract][Full Text] [Related]
2. Underutilization of gene expression profiling for early-stage breast cancer in California.
Cress RD; Chen YS; Morris CR; Chew H; Kizer KW
Cancer Causes Control; 2016 Jun; 27(6):721-7. PubMed ID: 27097910
[TBL] [Abstract][Full Text] [Related]
3. Racial Variation in the Uptake of Oncotype DX Testing for Early-Stage Breast Cancer.
Roberts MC; Weinberger M; Dusetzina SB; Dinan MA; Reeder-Hayes KE; Carey LA; Troester MA; Wheeler SB
J Clin Oncol; 2016 Jan; 34(2):130-8. PubMed ID: 26598755
[TBL] [Abstract][Full Text] [Related]
4. Racial and Ethnic Disparities in Oncotype DX Test Receipt in a Statewide Population-Based Study.
Davis BA; Aminawung JA; Abu-Khalaf MM; Evans SB; Su K; Mehta R; Wang SY; Gross CP
J Natl Compr Canc Netw; 2017 Mar; 15(3):346-354. PubMed ID: 28275035
[No Abstract] [Full Text] [Related]
5. Uptake of the 21-Gene Assay Among Women With Node-Positive, Hormone Receptor-Positive Breast Cancer.
Roberts MC; Kurian AW; Petkov VI
J Natl Compr Canc Netw; 2019 Jun; 17(6):662-668. PubMed ID: 31200352
[TBL] [Abstract][Full Text] [Related]
6. A tracking and feedback registry to reduce racial disparities in breast cancer care.
Bickell NA; Shastri K; Fei K; Oluwole S; Godfrey H; Hiotis K; Srinivasan A; Guth AA
J Natl Cancer Inst; 2008 Dec; 100(23):1717-23. PubMed ID: 19033569
[TBL] [Abstract][Full Text] [Related]
7. Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results.
Press DJ; Ibraheem A; Dolan ME; Goss KH; Conzen S; Huo D
Breast Cancer Res Treat; 2018 Feb; 168(1):207-220. PubMed ID: 29181717
[TBL] [Abstract][Full Text] [Related]
8. Racial differences in surgeons and hospitals for endometrial cancer treatment.
Armstrong K; Randall TC; Polsky D; Moye E; Silber JH
Med Care; 2011 Feb; 49(2):207-14. PubMed ID: 21150796
[TBL] [Abstract][Full Text] [Related]
9. Residual treatment disparities after oncology referral for rectal cancer.
Morris AM; Billingsley KG; Hayanga AJ; Matthews B; Baldwin LM; Birkmeyer JD
J Natl Cancer Inst; 2008 May; 100(10):738-44. PubMed ID: 18477800
[TBL] [Abstract][Full Text] [Related]
10. Disparities in Breast Cancer Survival by Socioeconomic Status Despite Medicare and Medicaid Insurance.
Silber JH; Rosenbaum PR; Ross RN; Reiter JG; Niknam BA; Hill AS; Bongiorno DM; Shah SA; Hochman LL; Even-Shoshan O; Fox KR
Milbank Q; 2018 Dec; 96(4):706-754. PubMed ID: 30537364
[TBL] [Abstract][Full Text] [Related]
11. Racial disparities in adoption of axillary sentinel lymph node biopsy and lymphedema risk in women with breast cancer.
Black DM; Jiang J; Kuerer HM; Buchholz TA; Smith BD
JAMA Surg; 2014 Aug; 149(8):788-96. PubMed ID: 25073831
[TBL] [Abstract][Full Text] [Related]
12. Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status.
Chen L; Li CI
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1666-72. PubMed ID: 26464428
[TBL] [Abstract][Full Text] [Related]
13. Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery?
Keating NL; Kouri E; He Y; Weeks JC; Winer EP
Med Care; 2009 Jul; 47(7):765-73. PubMed ID: 19536008
[TBL] [Abstract][Full Text] [Related]
14. Disparities in Use of Human Epidermal Growth Hormone Receptor 2-Targeted Therapy for Early-Stage Breast Cancer.
Reeder-Hayes K; Peacock Hinton S; Meng K; Carey LA; Dusetzina SB
J Clin Oncol; 2016 Jun; 34(17):2003-9. PubMed ID: 27069085
[TBL] [Abstract][Full Text] [Related]
15. Racial disparities in initiation of chemotherapy among breast cancer patients with discretionary treatment indication in the state of Georgia.
Collin LJ; Jones J; Nash R; Switchenko JM; Ward KC; McCullough LE
Breast Cancer Res Treat; 2024 Jun; 205(3):609-618. PubMed ID: 38517602
[TBL] [Abstract][Full Text] [Related]
16. The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis.
Lantz PM; Mujahid M; Schwartz K; Janz NK; Fagerlin A; Salem B; Liu L; Deapen D; Katz SJ
Am J Public Health; 2006 Dec; 96(12):2173-8. PubMed ID: 17077391
[TBL] [Abstract][Full Text] [Related]
17. Trends in disparities in receipt of adjuvant therapy for elderly stage III colon cancer patients: the role of the medical oncologist evaluation.
Davidoff AJ; Rapp T; Onukwugha E; Zuckerman IH; Hanna N; Pandya N; Mullins CD
Med Care; 2009 Dec; 47(12):1229-36. PubMed ID: 19786906
[TBL] [Abstract][Full Text] [Related]
18. Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study.
Felix AS; Cohn DE; Brasky TM; Zaino R; Park K; Mutch DG; Creasman WT; Thaker PH; Walker JL; Moore RG; Lele SB; Guntupalli SR; Downs LS; Nagel CI; Boggess JF; Pearl ML; Ioffe OB; Randall ME; Brinton LA
Am J Obstet Gynecol; 2018 Nov; 219(5):459.e1-459.e11. PubMed ID: 30096321
[TBL] [Abstract][Full Text] [Related]
19. Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.
Warner ET; Tamimi RM; Hughes ME; Ottesen RA; Wong YN; Edge SB; Theriault RL; Blayney DW; Niland JC; Winer EP; Weeks JC; Partridge AH
J Clin Oncol; 2015 Jul; 33(20):2254-61. PubMed ID: 25964252
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance contributes to racial disparities in breast cancer prognosis in US women.
Gallagher EJ; Fei K; Feldman SM; Port E; Friedman NB; Boolbol SK; Killelea B; Pilewskie M; Choi L; King T; Nayak A; Franco R; Cruz D; Antoniou IM; LeRoith D; Bickell NA
Breast Cancer Res; 2020 May; 22(1):40. PubMed ID: 32393319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
